Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1

Conditions

Anemia 11Anemia, Iron-Deficiency 6Neoplasms 4Colorectal Neoplasms 4Postoperative Complications 3Pancreatic Neoplasms 2Lymphoproliferative Disorders 2Adenocarcinoma 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Plexosarcoma 1Ovarian Neoplasms 1Liver Neoplasms 1Inflammatory Breast Neoplasms 1Gastrointestinal Stromal Tumors 1Endometrial Neoplasms 1Colonic Neoplasms 1Carcinoma, Ductal, Breast 1Cancer Anaemia 1Aortic Aneurysm 1Advanced Gastric Carcinoma 1

Interventions

Oxaliplatin 290Capecitabine 206Fluorouracil 181Cisplatin 168Docetaxel 138S 1 (combination) 132Paclitaxel 121Leucovorin 116Irinotecan 106pembrolizumab 103Trastuzumab 72apatinib 56Nivolumab 56sintilimab 45Drug Therapy 43Surgical Procedures, Operative 37Radiotherapy 37Bevacizumab 37Ramucirumab 34titanium silicide 31Hyperthermic Intraperitoneal Chemotherapy 30Epirubicin 30Carboplatin 30tislelizumab 28Cyclophosphamide 27XELOX 24Tegafur 23Folfox protocol 22Albumin-Bound Paclitaxel 22camrelizumab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Stomach Neoplasms × ferric carboxymaltose × Clear all
NCT04168346 2019-11-19

IRONSTOMACH

Helsinki University Central Hospital

Phase 4 Not yet recruiting
202 enrolled
Classical hematologyGastrointestinal

Anemia, Stomach Neoplasms, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡